Research graph
References from Clinicopathological and preoperative biomarkers associated with recurrence after primary surgical treatment for endometrial cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Endometrial cancer
10.1038/s41572-021-00324-8 · 2021 · External reference
Endometrial cancer: an overview of pathophysiology, management, and care
10.1016/j.soncn.2019.02.002 · 2019 · External reference
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy
10.1136/ijgc-2020-001822 · 2021 · External reference
Endometrial cancer
10.1016/s0140-6736(22)00323-3 · 2022 · External reference
Biomarker-driven therapy in endometrial cancer
10.1136/ijgc-2022-003676 · 2023 · External reference
An overview of endometrial cancer with novel therapeutic strategies
10.3390/curroncol30090574 · 2023 · External reference
Molecular evaluation of low-grade low-stage endometrial cancer with and without recurrence
10.1097/pgp.0000000000000798 · 2022 · External reference
The impact of perioperative events on cancer recurrence and metastasis in patients after radical gastrectomy: a review
10.3390/cancers14143496 · 2022 · External reference
Analysis of postoperative prognosis of non-metastatic endometrial carcinoma under different recurrence patterns
10.1038/s41598-025-12399-4 · 2025 · External reference
Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts
10.1158/1078-0432.ccr-15-2878 · 2016 · External reference
The contemporary presentation and diagnosis of endometrial cancer recurrence: when, where, and how
10.1016/j.ygyno.2022.09.014 · 2022 · External reference
Diagnostic roles of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, C-reactive protein, and cancer antigen 125 for ovarian cancer
10.1177/03000605231218557 · 2023 · External reference
High-dose-rate interstitial brachytherapy for vaginal endometrial cancer recurrence after prior surgery and radiotherapy
10.1016/j.brachy.2020.12.011 · 2021 · External reference
Isolated vaginal recurrence in women with stage I endometrial cancer
10.1016/j.ygyno.2023.10.011 · 2023 · External reference
Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification
10.1016/j.ygyno.2022.02.024 · 2022 · External reference
Tumor recurrence and tumor-related mortality in endometrial cancer: analysis in 276 patients
10.4103/0019-509x.178425 · 2015 · External reference
Blood-based biomarkers as predictive and prognostic factors in immunotherapy-treated patients with solid tumors-currents and perspectives
10.3390/cancers17122001 · 2025 · External reference
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
10.1016/j.jclinepi.2007.11.008 · 2008 · External reference
Radiation therapy with or without cisplatin for local recurrences of endometrial cancer: results from an NRG Oncology/GOG prospective randomized multicenter clinical trial
10.1200/jco.23.01279 · 2024 · External reference
Prognosis of endometrial cancer patients with and without symptoms at recurrence
10.1111/jog.13112 · 2016 · External reference
Adjuvant chemotherapy and radiation for patients with high-risk stage I endometrial cancer treated with curative intent surgery: impact on recurrence and survival
10.1136/ijgc-2021-003087 · 2022 · External reference
A nomogram for predicting recurrence in endometrial cancer patients: a population-based analysis
10.3389/fendo.2023.1156169 · 2023 · External reference
Clinical outcome of recurrent endometrial cancer: analysis of post-relapse survival by pattern of recurrence and secondary treatment
10.1136/ijgc-2019-000822 · 2020 · External reference
Current evidence-based systemic therapy for advanced and recurrent endometrial cancer
10.6004/jnccn.2022.7254 · 2023 · External reference
Potential biomarkers in endometrial cancer: a narrative review
10.1080/1354750x.2023.2179114 · 2023 · External reference
Detection of recurrence in early stage endometrial cancer - the role of symptoms and routine follow-up
10.1080/0284186x.2016.1267396 · 2017 · External reference
Features of recurrence of endometrioid type endometrial cancer of I stage
10.32471/exp-oncology.2312-8852.vol-43-no-4.17052 · 2021 · External reference
Detecting asymptomatic recurrence in early-stage endometrial cancer: the value of vaginal cytology, imaging studies, and CA-125
10.1097/igc.0000000000000797 · 2016 · External reference
Recurrence patterns and surveillance for patients with early stage endometrial cancer
10.1016/j.ygyno.2011.07.014 · 2011 · External reference
Recurrence risk factors in stage IA grade 1 endometrial cancer
10.3802/jgo.2021.32.e22 · 2021 · External reference
